{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:22:54Z","timestamp":1788639774083,"version":"build-2803163510"},"reference-count":141,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Amyotrophic lateral sclerosis is a devastating neurodegenerative disease for which the current treatment approaches remain severely limited. The principal pathological alterations of the disease include the selective degeneration of motor neurons in the brain, brainstem, and spinal cord, as well as abnormal protein deposition in the cytoplasm of neurons and glial cells. The biological markers under extensive scrutiny are predominantly located in the cerebrospinal fluid, blood, and even urine. Among these biomarkers, neurofilament proteins and glial fibrillary acidic protein most accurately reflect the pathologic changes in the central nervous system, while creatinine and creatine kinase mainly indicate pathological alterations in the peripheral nerves and muscles. Neurofilament light chain levels serve as an indicator of neuronal axonal injury that remain stable throughout disease progression and are a promising diagnostic and prognostic biomarker with high specificity and sensitivity. However, there are challenges in using neurofilament light chain to differentiate amyotrophic lateral sclerosis from other central nervous system diseases with axonal injury. Glial fibrillary acidic protein predominantly reflects the degree of neuronal demyelination and is linked to non-motor symptoms of amyotrophic lateral sclerosis such as cognitive impairment, oxygen saturation, and the glomerular filtration rate. TAR DNA-binding protein 43, a pathological protein associated with amyotrophic lateral sclerosis, is emerging as a promising biomarker, particularly with advancements in exosome-related research. Evidence is currently lacking for the value of creatinine and creatine kinase as diagnostic markers; however, they show potential in predicting disease prognosis. Despite the vigorous progress made in the identification of amyotrophic lateral sclerosis biomarkers in recent years, the quest for definitive diagnostic and prognostic biomarkers remains a formidable challenge. This review summarizes the latest research achievements concerning blood biomarkers in amyotrophic lateral sclerosis that can provide a more direct basis for the differential diagnosis and prognostic assessment of the disease beyond a reliance on clinical manifestations and electromyography findings.<\/jats:p>","DOI":"10.4103\/nrr.nrr-d-24-00286","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T04:03:45Z","timestamp":1727150625000},"page":"2556-2570","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis"],"prefix":"10.4103","volume":"20","author":[{"given":"Yongting","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2203-0046","authenticated-orcid":false,"given":"Hongfu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China"},{"name":"Department of Medical Genetics and Center for Rare disease, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China"},{"name":"Nanhu Brain-Computer Interface Institute, Hangzhou, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00415-020-09761-z","article-title":"Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis","volume":"267","author":"Abu-Rumeileh","year":"2020","journal-title":"J Neurol"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/bios13020247","article-title":"Electrochemical impedance immunoassay for ALS-associated neurofilament protein: matrix effect on the immunoplatform","volume":"13","author":"Adil","year":"2023","journal-title":"Biosensors (Basel)"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-017-00062-0","article-title":"Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation","volume":"8","author":"Afroz","year":"2017","journal-title":"Nat Commun"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bies.10251","article-title":"Neurofilaments and neurological disease","volume":"25","author":"Al-Chalabi","year":"2003","journal-title":"Bioessays"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.dci.2017.02.023","article-title":"miRNAs associated with immune response in teleost fish","volume":"75","author":"Andreassen","year":"2017","journal-title":"Dev Comp Immunol"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"fcad306","DOI":"10.1093\/braincomms\/fcad306","article-title":"Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF","volume":"5","author":"Audrain","year":"2023","journal-title":"Brain Commun"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.02870707","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"22128","DOI":"10.1038\/s41598-021-01499-6","article-title":"Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics","volume":"11","author":"Behzadi","year":"2021","journal-title":"Sci Rep"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","article-title":"Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"18","author":"Benigni","year":"2016","journal-title":"Neuromolecular Med"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocn.2015.10.008","article-title":"Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"26","author":"Benninger","year":"2016","journal-title":"J Clin Neurosci"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/acn3.51256","article-title":"TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis","volume":"8","author":"Beyer","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/ene.15813","article-title":"Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"30","author":"Brousse","year":"2023","journal-title":"Eur J Neurol"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/emboj\/20.7.1774","article-title":"Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping","volume":"20","author":"Buratti","year":"2001","journal-title":"EMBO J"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"1223096","DOI":"10.3389\/fimmu.2023.1223096","article-title":"Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis","volume":"14","author":"Calafatti","year":"2023","journal-title":"Front Immunol"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/cells9051174","article-title":"Creatine kinase and progression rate in amyotrophic lateral sclerosis","volume":"9","author":"Ceccanti","year":"2020","journal-title":"Cells"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","article-title":"Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS","volume":"30","author":"Chatterjee","year":"2024","journal-title":"Nat Med"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s10072-014-1807-4","article-title":"An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis","volume":"35","author":"Chen","year":"2014","journal-title":"Neurol Sci"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4103\/1673-5374.293159","article-title":"Creatine kinase in the diagnosis and prognostic prediction of amyotrophic lateral sclerosis: a retrospective case-control study","volume":"16","author":"Chen","year":"2021","journal-title":"Neural Regen Res"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/cells12040597","article-title":"TDP-43 proteinopathy specific biomarker development","volume":"12","author":"Cordts","year":"2023","journal-title":"Cells"},{"key":"R24-20260427","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamaneurol.2022.3265","article-title":"Distinguishing frontotemporal lobar degeneration tau from TDP-43 using plasma biomarkers","volume":"79","author":"Cousins","year":"2022","journal-title":"JAMA Neurol"},{"key":"R25-20260427","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De Schaepdryver","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-20260427","doi-asserted-by":"crossref","first-page":"120156","DOI":"10.1016\/j.lfs.2021.120156","article-title":"The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder","volume":"288","author":"Dhasmana","year":"2022","journal-title":"Life Sci"},{"key":"R27-20260427","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-019-0318-4","article-title":"The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders","volume":"14","author":"Didonna","year":"2019","journal-title":"Mol Neurodegener"},{"key":"R28-20260427","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI38339","article-title":"Introducing intermediate filaments: from discovery to disease","volume":"119","author":"Eriksson","year":"2009","journal-title":"J Clin Invest"},{"key":"R29-20260427","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1007\/s00415-020-09838-9","article-title":"Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease","volume":"267","author":"Falzone","year":"2020","journal-title":"J Neurol"},{"key":"R30-20260427","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/ene.15321","article-title":"Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis","volume":"29","author":"Falzone","year":"2022","journal-title":"Eur J Neurol"},{"key":"R31-20260427","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s40478-023-01676-w","article-title":"Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer\u2019s disease brain","volume":"11","author":"Frey","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"R32-20260427","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R33-20260427","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.3390\/ijms20174152","article-title":"Diagnostic and prognostic role of blood and cerebrospinal fluid and blood neurofilaments in amyotrophic lateral sclerosis: a review of the literature","volume":"20","author":"Gagliardi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R34-20260427","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1111\/jcmm.16240","article-title":"Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study","volume":"25","author":"Gagliardi","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R35-20260427","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol"},{"key":"R36-20260427","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1007\/s00415-022-11195-8","article-title":"Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis","volume":"269","author":"Gao","year":"2022","journal-title":"J Neurol"},{"key":"R37-20260427","doi-asserted-by":"crossref","first-page":"eadj9332","DOI":"10.1126\/scitranslmed.adj9332","article-title":"Immunological drivers of amyotrophic lateral sclerosis","volume":"15","author":"Gendron","year":"2023","journal-title":"Sci Transl Med"},{"key":"R38-20260427","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/21678421.2015.1062516","article-title":"Relationship of creatine kinase to body composition, disease state, and longevity in ALS","volume":"16","author":"Gibson","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R39-20260427","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R40-20260427","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/jcsm.13511","article-title":"Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population-based cohort","volume":"15","author":"Groothof","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R41-20260427","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/acn3.51299","article-title":"Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis","volume":"8","author":"Guo","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"R42-20260427","doi-asserted-by":"crossref","first-page":"154701","DOI":"10.1016\/j.prp.2023.154701","article-title":"Double-edged sword role of miRNA-633 and miRNA-181 in human cancers","volume":"248","author":"Gupta","year":"2023","journal-title":"Pathol Res Pract"},{"key":"R43-20260427","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R44-20260427","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp-2021-327129","article-title":"Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS","volume":"93","author":"Halbgebauer","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R45-20260427","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.clinph.2021.06.008","article-title":"Split-hand index: A diagnostic and prognostic marker in amyotrophic lateral sclerosis across varying regions of onset","volume":"132","author":"Hannaford","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"R46-20260427","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R47-20260427","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.4103\/1673-5374.389357","article-title":"Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study","volume":"19","author":"He","year":"2024","journal-title":"Neural Regen Res"},{"key":"R48-20260427","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"R49-20260427","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/acn3.51771","article-title":"Dynamic effects of prognostic factors and individual survival prediction for amyotrophic lateral sclerosis disease","volume":"10","author":"Huang","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"R50-20260427","first-page":"1155","article-title":"Glycometabolic reprogramming of microglia in neurodegenerative diseases: insights from neuroinflammation","volume":"15","author":"Huang","year":"2024","journal-title":"Aging Dis"},{"key":"R51-20260427","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1093\/brain\/aww237","article-title":"Exosome secretion is a key pathway for clearance of pathological TDP-43","volume":"139","author":"Iguchi","year":"2016","journal-title":"Brain"},{"key":"R52-20260427","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jns.2009.08.008","article-title":"Do serum uric acid levels reflect oxidative stress in the progression of ALS?","volume":"287","author":"Ikeda","year":"2009","journal-title":"J Neurol Sci"},{"key":"R53-20260427","doi-asserted-by":"crossref","first-page":"e075037","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"BMJ"},{"key":"R54-20260427","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10072-003-0158-3","article-title":"Creatine kinase activity in amyotrophic lateral sclerosis patients","volume":"24","author":"I\u0142zecka","year":"2003","journal-title":"Neurol Sci"},{"key":"R55-20260427","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1007\/s00415-019-09507-6","article-title":"Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis","volume":"266","author":"Ito","year":"2019","journal-title":"J Neurol"},{"key":"R56-20260427","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4103\/1673-5374.380873","article-title":"Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?","volume":"19","author":"Jourdi","year":"2024","journal-title":"Neural Regen Res"},{"key":"R57-20260427","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R58-20260427","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/acn3.50943","article-title":"Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS","volume":"6","author":"Kasai","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"R59-20260427","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/glia.20836","article-title":"Live imaging of amyotrophic lateral sclerosis pathogenesis: disease onset is characterized by marked induction of GFAP in Schwann cells","volume":"57","author":"Keller","year":"2009","journal-title":"Glia"},{"key":"R60-20260427","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"R61-20260427","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","article-title":"ALS genetics: gains, losses, and implications for future therapies","volume":"108","author":"Kim","year":"2020","journal-title":"Neuron"},{"key":"R62-20260427","doi-asserted-by":"crossref","first-page":"11682","DOI":"10.3390\/ijms241411682","article-title":"Creatine kinase MB isoenzyme is a complementary biomarker in amyotrophic lateral sclerosis","volume":"24","author":"Kittipeerapat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R63-20260427","doi-asserted-by":"crossref","first-page":"e0260323","DOI":"10.1371\/journal.pone.0260323","article-title":"Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP\u201343, and tau, and clinical characteristics","volume":"16","author":"Kojima","year":"2021","journal-title":"PLoS One"},{"key":"R64-20260427","doi-asserted-by":"crossref","first-page":"1275155","DOI":"10.3389\/fcell.2023.1275155","article-title":"Neurofilaments in health and Charcot-Marie-Tooth disease","volume":"11","author":"Kotaich","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R65-20260427","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-007-0226-5","article-title":"TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease","volume":"114","author":"Kwong","year":"2007","journal-title":"Acta Neuropathol"},{"key":"R66-20260427","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.3390\/ijms21218311","article-title":"Amyotrophic lateral sclerosis is accompanied by protein derangements in the olfactory bulb-tract axis","volume":"21","author":"Lach\u00e9n-Montes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R67-20260427","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/21678421.2019.1572192","article-title":"Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis","volume":"20","author":"Lanznaster","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R68-20260427","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00018-023-04797-6","article-title":"Neurofilament accumulations in amyotrophic lateral sclerosis patients\u2019 motor neurons impair axonal initial segment integrity","volume":"80","author":"Lefebvre-Omar","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"R69-20260427","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/glia.23734","article-title":"Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes","volume":"68","author":"Li","year":"2020","journal-title":"Glia"},{"key":"R70-20260427","doi-asserted-by":"crossref","first-page":"e2997","DOI":"10.1002\/brb3.2997","article-title":"Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study","volume":"13","author":"Li","year":"2023","journal-title":"Brain Behav"},{"key":"R71-20260427","doi-asserted-by":"crossref","first-page":"e1002338","DOI":"10.1371\/journal.pbio.1002338","article-title":"ALS-causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the intrinsically disordered prion-like domain of TDP-43","volume":"14","author":"Lim","year":"2016","journal-title":"PLoS Biol"},{"key":"R72-20260427","first-page":"189","article-title":"Increased creatine kinase and spontaneous activity on electromyography, in amyotrophic lateral sclerosis","volume":"43","author":"Lima","year":"2003","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"R73-20260427","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2023.05.030","article-title":"MicroRNA-23a-3p is upregulated in plasma exosomes of bulbar-onset ALS patients and targets ERBB4","volume":"524","author":"Liu","year":"2023","journal-title":"Neuroscience"},{"key":"R74-20260427","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2014-307672","article-title":"Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study","volume":"86","author":"Lu","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R75-20260427","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"R76-20260427","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet Neurol"},{"key":"R77-20260427","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","article-title":"Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis","volume":"24","author":"Magen","year":"2021","journal-title":"Nat Neurosci"},{"key":"R78-20260427","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur J Neurol"},{"key":"R79-20260427","doi-asserted-by":"crossref","first-page":"13976","DOI":"10.3390\/ijms241813976","article-title":"Amyloid-beta co-pathology is a major determinant of the elevated plasma GFAP values in amyotrophic lateral sclerosis","volume":"24","author":"Mastrangelo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R80-20260427","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","article-title":"GFAP in health and disease","volume":"93","author":"Middeldorp","year":"2011","journal-title":"Prog Neurobiol"},{"key":"R81-20260427","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R82-20260427","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/17482968.2010.495158","article-title":"Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)--a 20-year review: can we do better?","volume":"11","author":"Mitchell","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"R83-20260427","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/01.wnl.0000188907.97339.76","article-title":"Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?","volume":"65","author":"Moreau","year":"2005","journal-title":"Neurology"},{"key":"R84-20260427","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3390\/ijms20112759","article-title":"Are circulating cytokines reliable biomarkers for amyotrophic lateral sclerosis?","volume":"20","author":"Moreno-Martinez","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R85-20260427","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3389\/fimmu.2019.00801","article-title":"Circulating cytokines could not be good prognostic biomarkers in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Moreno-Martinez","year":"2019","journal-title":"Front Immunol"},{"key":"R86-20260427","doi-asserted-by":"crossref","first-page":"eadf6895","DOI":"10.1126\/sciadv.adf6895","article-title":"Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis","volume":"9","author":"Oiwa","year":"2023","journal-title":"Sci Adv"},{"key":"R87-20260427","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14728222.2022.2083958","article-title":"TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target","volume":"26","author":"Ojaimi","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"R88-20260427","first-page":"CD005225","article-title":"Creatine for amyotrophic lateral sclerosis\/motor neuron disease","volume":"12","author":"Pastula","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R89-20260427","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/ene.12754","article-title":"Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis","volume":"22","author":"Patin","year":"2015","journal-title":"Eur J Neurol"},{"key":"R90-20260427","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clinph.2023.09.018","article-title":"Utility of split hand index with different motor unit number estimation techniques in ALS","volume":"156","author":"Pavey","year":"2023","journal-title":"Clin Neurophysiol"},{"key":"R91-20260427","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"R92-20260427","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/07853890.2022.2153162","article-title":"Exosomal TAR DNA binding protein 43 profile in canine model of amyotrophic lateral sclerosis: a preliminary study in developing blood-based biomarker for neurodegenerative diseases","volume":"55","author":"Pfeiffer","year":"2023","journal-title":"Ann Med"},{"key":"R93-20260427","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1474-4422(07)70265-X","article-title":"Cognitive impairment in amyotrophic lateral sclerosis","volume":"6","author":"Phukan","year":"2007","journal-title":"Lancet Neurol"},{"key":"R94-20260427","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"R95-20260427","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","article-title":"Diagnostic and prognostic performance of neurofilaments in ALS","volume":"9","author":"Poesen","year":"2018","journal-title":"Front Neurol"},{"key":"R96-20260427","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2019.01.026","article-title":"Interleukin-6 and amyotrophic lateral sclerosis","volume":"398","author":"Pronto-Laborinho","year":"2019","journal-title":"J Neurol Sci"},{"key":"R97-20260427","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.3390\/ijms242015430","article-title":"The key role of astrocytes in amyotrophic lateral sclerosis and their commitment to glutamate excitotoxicity","volume":"24","author":"Provenzano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R98-20260427","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/ene.12995","article-title":"Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis","volume":"23","author":"Rafiq","year":"2016","journal-title":"Eur J Neurol"},{"key":"R99-20260427","doi-asserted-by":"crossref","first-page":"122945","DOI":"10.1016\/j.jns.2024.122945","article-title":"Differing patterns of cortical grey matter pathology identified by multifractal analysis in UMN-predominant ALS patients with and without corticospinal tract hyperintensity","volume":"459","author":"Rajagopalan","year":"2024","journal-title":"J Neurol Sci"},{"key":"R100-20260427","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.freeradbiomed.2019.12.043","article-title":"microRNA-181 serves as a dual-role regulator in the development of human cancers","volume":"152","author":"Rezaei","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"R101-20260427","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00018-022-04217-1","article-title":"Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes","volume":"79","author":"Rizzuti","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"R102-20260427","doi-asserted-by":"crossref","first-page":"123112","DOI":"10.1016\/j.jns.2024.123112","article-title":"High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS","volume":"463","author":"Ros\u00e9n","year":"2024","journal-title":"J Neurol Sci"},{"key":"R103-20260427","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jcmm.17100","article-title":"Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"26","author":"Shi","year":"2022","journal-title":"J Cell Mol Med"},{"key":"R104-20260427","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"R105-20260427","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","article-title":"The role of TDP-43 mislocalization in amyotrophic lateral sclerosis","volume":"15","author":"Suk","year":"2020","journal-title":"Mol Neurodegener"},{"key":"R106-20260427","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/ene.14409","article-title":"Blood biomarkers and prognosis of amyotrophic lateral sclerosis","volume":"27","author":"Sun","year":"2020","journal-title":"Eur J Neurol"},{"key":"R107-20260427","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fneur.2017.00322","article-title":"Correlation of creatine kinase levels with clinical features and survival in amyotrophic lateral sclerosis","volume":"8","author":"Tai","year":"2017","journal-title":"Front Neurol"},{"key":"R108-20260427","doi-asserted-by":"crossref","first-page":"14739","DOI":"10.1038\/s41598-022-18942-x","article-title":"Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset","volume":"12","author":"Theunissen","year":"2022","journal-title":"Sci Rep"},{"key":"R109-20260427","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ene.14063","article-title":"Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis","volume":"27","author":"Thouvenot","year":"2020","journal-title":"Eur J Neurol"},{"key":"R110-20260427","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","article-title":"Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression","volume":"19","author":"Tortelli","year":"2012","journal-title":"Eur J Neurol"},{"key":"R111-20260427","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/glia.23768","article-title":"Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL\u201334, and SCF in amyotrophic lateral sclerosis","volume":"68","author":"Trias","year":"2020","journal-title":"Glia"},{"key":"R112-20260427","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.24470","article-title":"Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis","volume":"51","author":"Turner","year":"2015","journal-title":"Muscle Nerve"},{"key":"R113-20260427","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","article-title":"Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation","volume":"22","author":"Tziortzouda","year":"2021","journal-title":"Nat Rev Neurosci"},{"key":"R114-20260427","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jnnp-2017-317077","article-title":"Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials","volume":"89","author":"van Eijk","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R115-20260427","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"R117-20260427","doi-asserted-by":"crossref","first-page":"679199","DOI":"10.3389\/fnins.2021.679199","article-title":"Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"15","author":"Verde","year":"2021","journal-title":"Front Neurosci"},{"key":"R118-20260427","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R119-20260427","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acn3.51708","article-title":"Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis","volume":"10","author":"Verde","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"R120-20260427","doi-asserted-by":"crossref","first-page":"815765","DOI":"10.3389\/fnins.2022.815765","article-title":"Expanding the TDP-43 proteinopathy pathway from neurons to muscle: physiological and pathophysiological functions","volume":"16","author":"Versluys","year":"2022","journal-title":"Front Neurosci"},{"key":"R121-20260427","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/17482968.2012.703208","article-title":"TDP-43 plasma levels are higher in amyotrophic lateral sclerosis","volume":"13","author":"Verstraete","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"R122-20260427","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13311-016-0503-x","article-title":"Fluid-based biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Vu","year":"2017","journal-title":"Neurotherapeutics"},{"key":"R123-20260427","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1007\/s12035-021-02309-w","article-title":"Serum creatinine protects against amyotrophic lateral sclerosis: a Mendelian Randomization Study","volume":"58","author":"Wang","year":"2021","journal-title":"Mol Neurobiol"},{"key":"R124-20260427","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4103\/1673-5374.382233","article-title":"The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R125-20260427","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/onc.2010.531","article-title":"Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM","volume":"30","author":"Wang","year":"2011","journal-title":"Oncogene"},{"key":"R126-20260427","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"R127-20260427","doi-asserted-by":"crossref","first-page":"e16154","DOI":"10.1111\/ene.16154","article-title":"Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis\u2014insights from a completed randomized controlled trial with rasagiline","volume":"31","author":"Witzel","year":"2024","journal-title":"Eur J Neurol"},{"key":"R128-20260427","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev"},{"key":"R129-20260427","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13024-023-00665-w","article-title":"Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms","volume":"18","author":"Xie","year":"2023","journal-title":"Mol Neurodegener"},{"key":"R130-20260427","doi-asserted-by":"crossref","first-page":"109436","DOI":"10.1016\/j.isci.2024.109436","article-title":"Lumbar puncture increases Alzheimer\u2019s disease biomarker levels in cerebrospinal fluid of rhesus monkeys","volume":"27","author":"Xu","year":"2024","journal-title":"iScience"},{"key":"R131-20260427","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4103\/1673-5374.357916","article-title":"A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G","volume":"18","author":"Yang","year":"2023","journal-title":"Neural Regen Res"},{"key":"R132-20260427","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/jnnp-2020-324615","article-title":"Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis","volume":"92","author":"Yamada","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R133-20260427","doi-asserted-by":"crossref","first-page":"e0179898","DOI":"10.1371\/journal.pone.0179898","article-title":"Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians","volume":"12","author":"Yen","year":"2017","journal-title":"PLoS One"},{"key":"R134-20260427","doi-asserted-by":"crossref","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R135-20260427","doi-asserted-by":"crossref","first-page":"689938","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci"},{"key":"R136-20260427","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/acn3.52066","article-title":"Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptoms","volume":"11","author":"Zejlon","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"R137-20260427","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1468-1331.2007.01972.x","article-title":"Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype","volume":"14","author":"Zetterberg","year":"2007","journal-title":"Eur J Neurol"},{"key":"R138-20260427","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4103\/1673-5374.353499","article-title":"Promising application of a new ulnar nerve compound muscle action potential measurement montage in amyotrophic lateral sclerosis: a prospective cross-sectional study","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen Res"},{"key":"R139-20260427","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4103\/1673-5374.355768","article-title":"Double-target neural circuit-magnetic stimulation improves motor function in spinal cord injury by attenuating astrocyte activation","volume":"18","author":"Zhao","year":"2023","journal-title":"Neural Regen Res"},{"key":"R140-20260427","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40035-021-00275-w","article-title":"Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia","volume":"10","author":"Zhu","year":"2021","journal-title":"Transl Neurodegener"},{"key":"R141-20260427","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1007\/s00253-017-8286-5","article-title":"Characterization of a functional recombinant human creatine kinase-MB isoenzyme prepared by tandem affinity purification from Escherichia coli","volume":"101","author":"Zou","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"R142-20260427","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Mol Neurodegener"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:37Z","timestamp":1787773237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":141,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-24-00286","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"2024-03-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}